SGEN | Seattle Genetics
Category: Biotechnology company
Next ER: April 27, 2023 After Market Closes
About the Company
Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer.
NASDAQ - Nasdaq Stock Market
More profiles and info about the company
This company doesn't provide a dividend.
Talk about Seattle Genetics below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
Buy on Amazon
Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.